National and Kapodistrian University of Athens
Ο ρόλος της κυτταρικής γήρανσης στη μη αλκοολική λιπώδη νόσο του ήπατος (NAFLD)
Abstract
dc:descriptionBackground: Non-alcoholic fatty liver disease (NAFLD) is the most predominant cause of chronic liver disease worldwide. The pathogenetic mechanisms involved in the progression of NAFLD have not been completely elucidated, while the circulating cell-free DNA (cfDNA) species have been implicated in a plethora of inflammatory diseases and malignancies. The significance of cfDNA species has been rarely evaluated in NAFLD while the assessment of the role of cellular senescence in the progression of NAFLD is of high clinical interest. In the current study, we aim to evaluate the role of both senescence and cfDNA species in the progression of NAFLD to non-alcoholic steatohepatitis (NASH) and liver cirrhosis. Methodology: In this cohort study, forty-nine adult patients with NAFLD of any stage ranging from simple steatosis (n=10) to NASH (n=23) and cirrhosis (n=16) were included. CfDNA was isolated from patients’ sera and the levels of several distinct cfDNA species including total cfDNA, gene-coding cfDNA, Alu repeat sequences and mitochondrial DNA copies were determined. Moreover, we evaluated the global methylation of cfDNA as assessed by the levels of 5-methyl-2′-deoxycytidine as well as the gene specific methylation of CDKN1A (p21), CDKN2A (p16) και RB1 genes, all of which are major regulators of cellular senescence. Results: Cirrhotic compared to non-cirrhotic patients had significantly lower serum levels of cfDNA (72.6 vs. 27.9 ng/mL, p = 0.002) and RNAse P coding DNA (70.2 vs. 39.9 GEs, p < 0.001) as well as higher expression of 5-methyl-2′-deoxycytidine (170.3 vs. 145.1 ng/mL, p = 0.029). After adjustment for the significant clinico-epidemiological factors, lower serum levels of cfDNA or RNAse P were independently associated with the presence of cirrhosis. Moreover, cirrhotic patients had significantly lower mean methylation of RB1 gene in serum as compared to non-cirrhotic patients (0.77% vs 1.08%, p=0.050), whereas patients with NASH or NASH-associated cirrhosis had remarkably decreased mean methylation of CDKN1A (p21) gene in serum in comparison to their counterparts with isolated steatosis (1.16% vs 2.62%, p=0.025).Conclusions: In conclusion, serum levels of total and gene-coding DNA are associated with the presence of cirrhosis in NAFLD patients regardless of clinical or epidemiological parameters and may therefore be used as a screening tool for NAFLD progression. Additionally, the CDKN1A (p21), CDKN12A (p16) and RB1 genes, major regulatory molecules of cellular senescence, seem to be implicated in the progression of NAFLD to NASH and cirrhosis.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Chrysavgis, Lampros
- Χρυσαυγής, Λάμπρος
Subjects
dc:subject × 16- Μη αλκοολική λιπώδης νόσος του ήπατος
- Κυτταρική γήρανση
- Κίρρωση του ήπατος
- Κυκλοφορούν DNA
- Μεθυλίωση του DNA
- Non-alcoholic fatty liver disease
- Cellular senescence
- Liver cirrhosis
- Cell-free DNA
- DNA methylation
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Ηπατολογία
- Clinical Medicine
- Medical and Health Sciences
- Hepatology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/55382